Literature DB >> 4621662

Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis.

H Gleichmann, E Gleichmann, J André-Schwartz, R S Schwartz.   

Abstract

The pathogenesis of glomerulonephritis in F(1) hybrid mice injected with parental spleen cells was investigated in several ways. Whenever glomerulonephritis developed, the lesion had the typical morphology produced by antigen-antibody complexes. Experiments employing backcross mice demonstrated that the antigen is supplied by the recipient and that it is specified by the H-2 gene complex, or by a locus closely linked to H-2. The source of the antibody was investigated by staining glomerular lesions with fluorescein isothiocyanate-tagged anti-immunoglobulin allotype sera. Only donor-type allotypes could be detected. The ability of the donor's immunocytes to respond to the recipient's histocompatibility antigens in such a way as to produce nephritogenic immune complexes varied from strain to strain, and seemed to be controlled by a gene unrelated to H-2. The results suggest that cell surface antigens, such as histocompatibility antigens, may be of importance in the pathogenesis of several kinds of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4621662      PMCID: PMC2139130          DOI: 10.1084/jem.135.3.516

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  The passenger cell concept in transplantation immunology.

Authors:  R E Billingham
Journal:  Cell Immunol       Date:  1971-02       Impact factor: 4.868

2.  Immunological studies in nephrotic syndrome associated with extrarenal malignant disease.

Authors:  M G Lewis; L W Loughridge; T M Phillips
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

3.  Cytolysis of mouse lymph node cells by alloantibody: a comparison of guinea-pig and rabbit complements.

Authors:  G Haughton; M P McGehee
Journal:  Immunology       Date:  1969-04       Impact factor: 7.397

4.  Human renal transplants. 3. Immunopathologic studies.

Authors:  G A Andres; L Accinni; K C Hsu; I Penn; K A Porter; J M Rendall; B C Seegal; T E Starzl
Journal:  Lab Invest       Date:  1970-06       Impact factor: 5.662

5.  Soluble HL-A7 antigen: localization in the beta-lipoprotein fraction of human serum.

Authors:  R K Charlton; C M Zmijewski
Journal:  Science       Date:  1970-11-06       Impact factor: 47.728

6.  Acute nephrotic syndrome as a manifestation of active Hodgkin's Disease. Report of four cases and review of the literature.

Authors:  J Plager; L Stutzman
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

7.  Strain C57BL-10ScSn and its congenic resistant sublines.

Authors:  J H Stimpfling; A E Reichert
Journal:  Transplant Proc       Date:  1970-03       Impact factor: 1.066

8.  Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

Authors:  J Churg; R Habib; R H White
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

9.  Leucocyte antigens and disease. I. Association of HL-A2 and chronic glomerulonephritis.

Authors:  R Patel; M R Mickey; P I Terasaki
Journal:  Br Med J       Date:  1969-05-17

10.  Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strains.

Authors:  G Cudkowicz
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  11 in total

1.  [Correlation of splenomegaly and blood picture changes in graft vs host reaction of the mouse].

Authors:  C Witting; W Detlefsen
Journal:  Blut       Date:  1975-10

2.  Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus.

Authors:  B P Tsao; F M Ebling; C Roman; N Panosian-Sahakian; K Calame; B H Hahn
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 3.  Mechanisms of autoimmunity.

Authors:  Robert Eisenberg
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Genetics of experimental lupus nephritis: non-H-2 factors determine susceptibility for renal involvement in murine chronic graft-versus-host disease.

Authors:  J A Bruijn; E H Van Elven; W E Corver; M Oudshoorn-Snoek; G J Fleuren
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

5.  Specificity of anti-nuclear antibodies induced in F1 mice undergoing the graft-vs-host reaction: isotypes and cross-reactivities.

Authors:  M Kimura; S Ida; K Shimada; Y Kanai
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

6.  Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E).

Authors:  M Kimura; F M van Rappard-van der Veen; E Gleichmann
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

7.  Transmission of auto-immune haemolytic anaemia and murine leukaemia virus in NZB-BALB/c hybrid mice.

Authors:  J East; J J Harvey; R Tilly
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

8.  Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease.

Authors:  J A Bruijn; P C Hogendoorn; W E Corver; L J van den Broek; P J Hoedemaeker; G J Fleuren
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

9.  Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.

Authors:  E H Van Elven; A G Rolink; F V Veen; E Gleichmann
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.

Authors:  A G Rolink; S T Pals; E Gleichmann
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.